Description
PRINCIPIO ACTIVO: CINARIZINA
Prevención y tratamiento del rechazo agudo en trasplante de órganos
PRINCIPIO ACTIVO: AMBROXOL
Síndrome mano-pie
Leucemia linfoblástica aguda (LLA) Ph+
NEURONTIN 600 MG 15 TAB BUTENAFINA PRINCIPIO ACTIVO: CINARIZINAPRINCIPIO ACTIVO: GABAPENTINA DOSIS: 600 MG FORMA FARMACUTICA: 15 TABLETAS PRESENTACIN: 1 CAJA
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
You may also like
recommand products
